Page last updated: 2024-08-26

4-hydroxycyclophosphamide and B-Cell Chronic Lymphocytic Leukemia

4-hydroxycyclophosphamide has been researched along with B-Cell Chronic Lymphocytic Leukemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bontemps, F; Cardoen, S; Delacauw, A; Deneys, V; Ferrant, A; Gillis, E; Leveugle, P; Louviaux, I; Scheiff, JM; Van den Berghe, G; Van Den Neste, E	1

Other Studies

1 other study(ies) available for 4-hydroxycyclophosphamide and B-Cell Chronic Lymphocytic Leukemia

Article	Year
Potentiation of antitumor effects of cyclophosphamide derivatives in B-chronic lymphocytic leukemia cells by 2-chloro-2'-deoxyadenosine. Leukemia, 1999, Volume: 13, Issue:6 Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Cell Survival; Cladribine; Cyclophosphamide; Drug Screening Assays, Antitumor; Drug Synergism; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Time Factors; Tritium; Tumor Cells, Cultured	1999

Article

Year

Potentiation of antitumor effects of cyclophosphamide derivatives in B-chronic lymphocytic leukemia cells by 2-chloro-2'-deoxyadenosine.

Leukemia, 1999, Volume: 13, Issue:6

Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Cell Survival; Cladribine; Cyclophosphamide; Drug Screening Assays, Antitumor; Drug Synergism; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Time Factors; Tritium; Tumor Cells, Cultured

1999